271 related articles for article (PubMed ID: 31372722)
1. Protein expression of close homologue of L1 (CHL1) is a marker for overall survival in non-small cell lung cancer (NSCLC).
Hötzel J; Melling N; Müller J; Polonski A; Wolters-Eisfeld G; Izbicki JR; Karstens KF; Tachezy M
J Cancer Res Clin Oncol; 2019 Sep; 145(9):2285-2292. PubMed ID: 31372722
[TBL] [Abstract][Full Text] [Related]
2. Ly6/uPAR-related protein C4.4A as a marker of solid growth pattern and poor prognosis in lung adenocarcinoma.
Jacobsen B; Muley T; Meister M; Dienemann H; Christensen IJ; Santoni-Rugiu E; Lærum OD; Ploug M
J Thorac Oncol; 2013 Feb; 8(2):152-60. PubMed ID: 23287851
[TBL] [Abstract][Full Text] [Related]
3. PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups.
Schmidt LH; Kümmel A; Görlich D; Mohr M; Bröckling S; Mikesch JH; Grünewald I; Marra A; Schultheis AM; Wardelmann E; Müller-Tidow C; Spieker T; Schliemann C; Berdel WE; Wiewrodt R; Hartmann W
PLoS One; 2015; 10(8):e0136023. PubMed ID: 26313362
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological significance of the expression of PD-L1 in non-small cell lung cancer.
Montero MA; Aricak O; Kis L; Yoshikawa A; De Petris L; Grundberg O; Pham HHN; Roden AC; Fukuoka J; Attanoos R; Guijarro R; Alarcón F; Lindström K; Ortiz-Villalón C
Ann Diagn Pathol; 2021 Apr; 51():151701. PubMed ID: 33485052
[TBL] [Abstract][Full Text] [Related]
5. Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma.
Pelosi G; Pasini F; Sonzogni A; Maffini F; Maisonneuve P; Iannucci A; Terzi A; De Manzoni G; Bresaola E; Viale G
Cancer; 2003 May; 97(10):2487-97. PubMed ID: 12733148
[TBL] [Abstract][Full Text] [Related]
6. Vasohibin-1 expression detected by immunohistochemistry correlates with prognosis in non-small cell lung cancer.
Zhang T; Yu TT; Zhang DM; Hou XM; Liu XJ; Zhao D; Shan L
Med Oncol; 2014 May; 31(5):963. PubMed ID: 24748406
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of combinations of RNA-dependent protein kinase and EphA2 biomarkers for NSCLC.
Guo C; Shao R; Correa AM; Behrens C; Johnson FM; Raso MG; Prudkin L; Solis LM; Nunez MI; Fang B; Roth JA; Wistuba II; Swisher SG; Lin T; Pataer A
J Thorac Oncol; 2013 Mar; 8(3):301-8. PubMed ID: 23370317
[TBL] [Abstract][Full Text] [Related]
8. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
Dong X; Lin D; Low C; Vucic EA; English JC; Yee J; Murray N; Lam WL; Ling V; Lam S; Gout PW; Wang Y
J Thorac Oncol; 2013 Feb; 8(2):161-70. PubMed ID: 23287853
[TBL] [Abstract][Full Text] [Related]
9. mTOR and PTEN expression in non-small cell lung cancer: analysis by real-time fluorescence quantitative polymerase chain reaction and immunohistochemistry.
Wang L; Yue W; Zhang L; Zhao X; Wang Y; Xu S
Surg Today; 2012 May; 42(5):419-25. PubMed ID: 22127531
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of 14-3-3γ overexpression in advanced non-small cell lung cancer.
Raungrut P; Wongkotsila A; Lirdprapamongkol K; Svasti J; Geater SL; Phukaoloun M; Suwiwat S; Thongsuksai P
Asian Pac J Cancer Prev; 2014; 15(8):3513-8. PubMed ID: 24870749
[TBL] [Abstract][Full Text] [Related]
11. L1CAM protein expression is associated with poor prognosis in non-small cell lung cancer.
Tischler V; Pfeifer M; Hausladen S; Schirmer U; Bonde AK; Kristiansen G; Sos ML; Weder W; Moch H; Altevogt P; Soltermann A
Mol Cancer; 2011 Oct; 10():127. PubMed ID: 21985405
[TBL] [Abstract][Full Text] [Related]
12. Prognostic effect of matrix metalloproteinase-9 in patients with resected Non small cell lung cancer.
Lee CY; Shim HS; Lee S; Lee JG; Kim DJ; Chung KY
J Cardiothorac Surg; 2015 Mar; 10():44. PubMed ID: 25888323
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of immunohistochemical expressions of p53, HER-2/neu, and bcl-2 in stage I non-small-cell lung cancer.
Han H; Landreneau RJ; Santucci TS; Tung MY; Macherey RS; Shackney SE; Sturgis CD; Raab SS; Silverman JF
Hum Pathol; 2002 Jan; 33(1):105-10. PubMed ID: 11823980
[TBL] [Abstract][Full Text] [Related]
14. High expression of FOXC1 is associated with poor clinical outcome in non-small cell lung cancer patients.
Wei LX; Zhou RS; Xu HF; Wang JY; Yuan MH
Tumour Biol; 2013 Apr; 34(2):941-6. PubMed ID: 23264086
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer.
Wang D; Hao T; Pan Y; Qian X; Zhou D
Mol Cell Biochem; 2015 Apr; 402(1-2):75-82. PubMed ID: 25567207
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of phosphorylated mTOR/RPS6KB1 in non- small cell lung cancer.
Zhang Y; Ni HJ; Cheng DY
Asian Pac J Cancer Prev; 2013; 14(6):3725-8. PubMed ID: 23886172
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological and prognostic significance of hypoxia-inducible factor-1 alpha in lung cancer: a systematic review with meta-analysis.
Yang SL; Ren QG; Wen L; Hu JL
J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):321-327. PubMed ID: 27376798
[TBL] [Abstract][Full Text] [Related]
18. Prognostic effect of intratumoral neutrophils across histological subtypes of non-small cell lung cancer.
Rakaee M; Busund LT; Paulsen EE; Richardsen E; Al-Saad S; Andersen S; Donnem T; Bremnes RM; Kilvaer TK
Oncotarget; 2016 Nov; 7(44):72184-72196. PubMed ID: 27708229
[TBL] [Abstract][Full Text] [Related]
19. Assessing PDL-1 and PD-1 in Non-Small Cell Lung Cancer: A Novel Immunoscore Approach.
Paulsen EE; Kilvaer TK; Khanehkenari MR; Al-Saad S; Hald SM; Andersen S; Richardsen E; Ness N; Busund LT; Bremnes RM; Donnem T
Clin Lung Cancer; 2017 Mar; 18(2):220-233.e8. PubMed ID: 27816392
[TBL] [Abstract][Full Text] [Related]
20. Expression of p114RhoGEF predicts lymph node metastasis and poor survival of squamous-cell lung carcinoma patients.
Song C; Gao Y; Tian Y; Han X; Chen Y; Tian DL
Tumour Biol; 2013 Jun; 34(3):1925-33. PubMed ID: 23512329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]